Dr Kate Cameron performs
pioneering work within liver cell physiology and differentiation of
drug-inducible hepatocytes from human ES and iPS cells. She has over 10 years
in stem cell experience and 5 in hepatocyte differentiation. She has pushed the
front line forward by making cGMP translatable hepatocytes in a defined system,
this has been published and patented. She
has led the way in optimising hepatocyte differentiation in automated systems
and developing Cytochroma as a business. She has recently begun the prestegious Royal society of Edinburgh Enterprise Fellowship programme, funded by the BBSRC.